This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

SEC Lifts Ban, Apple Ruling: Ahead of the Ticker

Stocks in this article: AAPL GSK

NEW YORK ( TheStreet) -- A U.S. district judge has found Apple (AAPL) guilty of colluding with book publishers to raise e-book prices, a violation of federal antitrust law.

The U.S. Department of Justice alleged that Apple's conspiracy was intended to challenge's (AMZN) dominance in the e-book market. Apple and book publishers allegedly colluded on ways to raise e-book prices above the $9.99 price tag Amazon often used.

"Apple chose to join forces with the publisher defendants to raise e-book prices and equipped them with the means to do so," said U.S. District Judge Denise Cote in her decision.

Cote said a new hearing will be scheduled to determine damages. Book publishers Hachette Book Group, Macmillan, HarperCollins Publishers, Penguin Group and Simon & Schuster all settled with the Department of Justice prior to the trial.

An Apple spokesman said the company did not conspire to fix e-book pricing and will appeal the judge's decision.

In other news, the Securities and Exchange Commission has removed a ban on hedge funds using advertisements to raise money.

The SEC voted 4 to 1 in favor of changing the rule, which will allow firms to advertise publicly to anyone they want. However, only accredited investors with a minimum net worth of $1 million, excluding their primary residence, or income of at least $200,000 a year for each of the prior two years will be permitted to invest in the private offerings.

The rule was originally included in Congress' Jumpstart Our Business Startups Act last year, which aimed to help small businesses and create jobs.

Hedge funds and other firms will able to begin advertising to the public later this year.

Under the ban, hedge funds and similar companies were only allowed to market to wealthy individuals.

Lastly, Chinese investigators said executives of British drug company GlaxoSmithKline (GSK) have confessed to acts of corruption within the company.

According to the Ministry of Public Security, GlaxoSmithKline executives admitted to bribery and tax crimes in preliminary questioning. The ministry said in a statement that the individuals committed the fraudulent acts in order to sell products or raise prices.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs